Society of Gynecologic Oncology

Advancing gynecologic cancer care requires collaboration, commitment, and community. In reflections from the SGO 2026 Annual Meeting on Women’s Cancer in CURE®, Ginger J. Gardner, MD, FACOG, Chair for the Foundation for Women’s Cancer, underscores the value of convening clinicians and researchers to accelerate discovery, translate research into patient centered care, and prioritize equitable access to innovation. Face to face scientific collaboration drives deeper problem solving, renewed commitment, and progress in women’s cancer care. Read the full CURE article: https://lnkd.in/esqJtY-j #SGOAM26 #GynOnc #CancerCare

SGO members, patient advocates and staff came together to Washington, D.C., for the 2026 SGO Advocacy Day to ensure the voices of the gynecologic cancer community were heard on Capitol Hill. They discussed priorities including sustained federal research funding for endometrial cancer and continued support for gynecologic cancer education and awareness through the CDC. Additionally, they shared firsthand perspectives on the policies shaping the future of gynecologic oncology. Their message was clear: continued investment in research, education, and access to specialized care is critical for patients and families affected by gynecologic cancers. Read the full Advocacy Day recap to learn more about the conversations, priorities, and impact of this year’s advocacy efforts. https://lnkd.in/eZXMUTNW #GynecologicOncology #WomensCancer #HealthPolicy #Advocacy

The Society of Gynecologic Oncology has released Part II of its evidence-based review on endometrial cancer, focusing on updated recommendations for fertility-sparing management, systemic therapy, and survivorship. Key updates include: ▶️ Progestin-based therapy remains a cornerstone of fertility preservation for select patients. ▶️ Randomized phase III trials now support chemotherapy plus checkpoint blockade as the standard first-line therapy for advanced and recurrent endometrial cancer, independent of measurable disease status. ▶️ Molecular and pathologic testing is essential for guiding systemic therapy selection. ▶️ Recurrent disease management requires a multimodal, individualized strategy to optimize outcomes. Read the full review: https://lnkd.in/eUWaRJcp #EndometrialCancer #GynecologicOncology #CancerCare

Today, SGO members, patient advocates and staff are on Capitol Hill moving the message for SGO 2026 Advocacy Day. We’re meeting with lawmakers to advocate for policies that support gynecologic cancer research, improve patient access to care, and strengthen education and awareness efforts nationwide. We’re proud to bring the voices of physicians, researchers, and patients directly to Congress as we work to advance care for those affected by gynecologic cancers. Stay tuned for our full Advocacy Day recap. #GynecologicOncology #WomensCancer #HealthPolicy #Advocacy

Cancer drug shortages continue to threaten timely access to life-saving treatments for patients nationwide. Today, SGO joined leading organizations across the cancer community in issuing a consensus statement calling for urgent policy action to address the ongoing U.S. drug shortages. The statement highlights three key priorities: • Greater supply chain transparency • Stronger incentives for resilient manufacturing • Stabilization of the generic drug market Read the full statement on our website. https://lnkd.in/eSq6uAbu #GynecologicOncology #GynOnc #WomensCancer #DrugShortages

Pamela T. Soliman, MD, MPH, discusses how data presented at the Society of Gynecologic Oncology 2026 Annual Meeting on #WomensCancer in Puerto Rico may expand HER2-directed treatment options for patients with advanced and recurrent #EndometrialCancer. #SGO26 #Cancer #Oncology #MedEd #md https://lnkd.in/eiW_v8eH

📢 Call for Papers | Special Issue in Gynecologic Oncology Gynecologic Oncology invites submissions for a Special Issue on Precision, Progress, and Promise: Updates in Biomarkers, Rare Tumors, and the Future of Gynecologic Oncology Trials. This Special Issue highlights the momentum shaping clinical trials in our field, from innovative trial design to advances in biomarkers and rare tumors. The Journal welcomes: - Original research - Trial results - Trials in progress - Invited review articles - Historical or perspective manuscripts aligned with themes of rare tumors, biomarker innovation, and trial design 🗓 Submission deadline: June 15, 2026 Join us in shaping the future of gynecologic oncology research. Submit your manuscript and learn more about this issue: https://lnkd.in/e9jajarW

If you were born with ovaries, you are at risk of ovarian cancer, but no one should face that possibility alone. Access to information, awareness, and support can make all the difference, and timely care can save lives. Symptoms of ovarian cancer can include: - Persistent bloating - Feeling full quickly or loss of appetite - Pain or discomfort in the lower abdomen or back - Needing to urinate more often or urgently On this World Ovarian Cancer Day, listen to your body, trust your voice, and #AskHer. Ask her about her symptoms. Ask her when she last received routine care. Asking questions can lead to earlier diagnosis and save lives. #FoundationForWomansCancer #WorldOvarianCancerDay #OvarianCancerAwareness #FWC #GynecologicCancer #GynOnc #SGO

📢 Join us for an upcoming webinar hosted by Gynecologic Oncology Reports on May 11. Whether you are preparing your first case report or looking to strengthen your publication strategy, this session will provide practical guidance for researchers, clinicians, and authors working across gynecologic oncology and case report publishing. 🔎 What to expect: • Best practices for preparing impactful case reports • Tips for navigating the submission and peer review process • Insights from journal and publishing experts • Live Q&A with attendees This webinar may be especially valuable for authors interested in publishing in case report journals and advancing clinical knowledge through real-world patient experiences. 📅 Date: May 11 🖥️ Register here: https://lnkd.in/eeaitEAc We look forward to welcoming researchers and clinicians from across the community. #GynecologicOncology #CaseReports #AcademicPublishing #ResearcherAcademy #MedicalResearch #ClinicalResearch #Elsevier #OpenAccess #PublishingTips